Coronavirus vaccine could be on market in mid-2021 - CureVac
Coronavirus chronicle
17 June, 2020, 04:30 pm
Last modified: 17 June, 2020, 04:31 pm
CureVac might be able to apply for approval early next year, Klaus Cichutek, President of German vaccine regulator PEI, added during a joint videoconference
Representational Image. Photo: Reuters
A vaccine against the coronavirus pandemic by CureVac could be on the market in mid-2021, the unlisted German company said on Wednesday.
CureVac might be able to apply for approval early next year, Klaus Cichutek, President of German vaccine regulator PEI, added during a joint videoconference
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.